Crystal violet Assay Kit (Cell viability)
Be the first to review this product! Submit a review
|
(40 Publications)
Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
- Cytotox
Supplier Data
Microcytotoxicity testing - Crystal violet Assay Kit (Cell viability) (AB232855)
Dose-response curve of MCF7 (Human breast adenocarcinoma cell line) cells to Doxorubicin for 72 hours determined by the Crystal violet staining assay. Assays were performed according to the kit protocol in triplicate.
- Cytotox
Supplier Data
Microcytotoxicity testing - Crystal violet Assay Kit (Cell viability) (AB232855)
Dose-response curve of HepG2 (Human liver hepatocellular carcinoma cell line) cells to Doxorubicin for 72 hours determined by the Crystal violet staining assay. Assays were performed according to the kit protocol in triplicate.
Product details
Crystal Violet Assay Kit ab232855 is used for cytoxicity and cell viability studies with adherent cell cultures.
Crystal violet assay principle
The Crystal Violet assay is based on staining cells that are attached to cell culture plates. It relies on the detachment of adherent cells from cell culture plates during cell death. During the assay, dead detached cells are washed away. The remaining attached live cells are stained with Crystal violet. After a wash step, the Crystal violet dye is solubilized and measured by absorbance at 570 nm.
The amount of Crystal Violet staining in the assay is directly proportional to the cell biomass that is attached to the plate. The cell biomass can be used to infer levels of cell viability / cytotoxicity. The Crystal Violet assay assumes that all cells that are attached to the plate are "alive" and that all cells that detach are "dead".
Crystal violet is a triarylmethane dye that binds to ribose type molecules such as DNA in nuclei.
Crystal Violet assay protocol summary:
- remove culture medium
- wash cells
- add Crystal Violet staining solution
- incubate for 20 mins
- wash cells and air dry plate
- add solubilization solution
- analyze using a microplate reader at 570 nm absorbance
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (40)
Recent publications for all applications. Explore the full list and refine your search
Biofilm 9:100285 PubMed40496336
2025
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 182:3923-3951 PubMed40344208
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed40332124
2025
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 29:71 PubMed39991715
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed39859304
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:26038 PubMed39472715
2024
Applications
Unspecified application
Species
Unspecified reactive species
World journal of gastrointestinal oncology 16:3994-4005 PubMed39350979
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 30: PubMed39301652
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 13: PubMed38995006
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 52: PubMed38874019
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com